PTC Therapeutics, Inc. (PTCT)
73.53
+2.66
(+3.75%)
USD |
NASDAQ |
Jun 09, 15:51
PTC Therapeutics SG&A Expense (Quarterly) : 86.18M for March 31, 2026
SG&A Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
SG&A Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
SG&A Expense (Quarterly) Benchmarks
| Keros Therapeutics, Inc. | 10.15M |
| Insmed, Inc. | 247.26M |
| Madrigal Pharmaceuticals, Inc. | 268.52M |
| Protagonist Therapeutics, Inc. | 13.28M |
| Arcutis Biotherapeutics, Inc. | 74.08M |